News

A new study published in The Lancet, involving researchers from the University of Liverpool and Alder Hey Children's Hospital Trust, has identified a 'user friendly' treatment for the most common life-threatening neurological emergency in children.

Researchers describe a new experimental model of Congenital hepatic fibrosis (CHF), which allowed them to uncover molecular players that may contribute to the illness.

Scientists have used an experimental therapy that relies on bacteria-infecting viruses collected, in part, through HHMI’s SEA-PHAGES program to fight a Mycobacterium infection in a 15-year-old girl.

A study at The University of Texas MD Anderson Cancer Center demonstrated how a small molecule drug discovered at the institution may help overcome resistance to treatment with ibrutinib in patients with mantle cell lymphoma.

Honey is a culinary staple that can be found in kitchens around the world. Humans have used honey throughout history, and its long shelf life and medicinal properties make it a unique, multipurpose natural product. Now, researchers report new data on honey proteins that could lead to new medicinal applications.

Nearly ninety per cent of all cancer patient deaths are due to metastasis. A study shows that a process that allows the cells to metastasise is aided by the synthesis of new ribosomes, the cell components in which proteins are produced.

Researchers say they have further characterized a set of chemical imbalances in the brains of people with schizophrenia related to the chemical glutamate. And they figured out how to tweak the level using a compound derived from broccoli sprouts.

Montmorency tart cherries reduced systolic blood pressure, insulin levels and insulin concentrations in adults with metabolic syndrome participating in a small pilot study.

Researchers have discovered a previously unknown signaling pathway that regulates surface proteins on bacteria that can lead to new targets for antibiotics.

Aptamer Therapeutics Limited is pleased to announce a new collaboration with Dan Wiseman and the Oglesby Leukaemia Research Programme at the University of Manchester and Cancer Research UK. The project will explore the potential of aptamers as therapeutic agents for the treatment of chronic myelomonocytic leukemia and other myeloid malignancies.